All Cell Content

Bringing you the latest research surrounding the safety, efficacy and characterisation of cell & gene therapies, targeted approaches for cell line development, optimised cell media techniques, and more, through a range of Speaker Interviews, Industry Insights, and Expert Opinions.

Written Q&A
Discover key insights into the application of microphysiological systems for advanced kidney and prostate cancer research.
27 July 2022
Tissue Engineering & 3D Models
Commentary
Katrina Adlerz, Scientist at The University of Texas MD Anderson Cancer Center presents on developing meaningful biologic assays at the Cell Therapy Analytics Symposium 2022.
28 June 2022
Cell & Gene Therapy Manufacturing
Discussion Group Report
June’s Discussion Group welcomed a panel of industry experts to debate manufacturing and standardisation challenges for the commercialisation of cell and gene therapies.
Edited by Tia Byer |
21 June 2022
Cell & Gene Therapy Manufacturing
Insight Article
Key opinion leaders from Roche and Purespring Therapeutics debate future strategies for advancing cell and gene therapeutics.
Edited by Tia Byer |
15 June 2022
Gene Therapy Development
Commentary
In this Commentary article, we explore how reductions in testing complexity can improve access to hematopoietic stem cell therapies for patients with blood disorders. The provision of safe, effective therapies will help to ameliorate the worst impacts of these disorders for patients and afford them a better quality of life.
15 June 2022
Stem Cell Development & Manufacturing
Whitepaper
13 June 2022
Cell Therapy Development
Whitepaper
13 June 2022
Cell Therapy Development
Whitepaper
13 June 2022
Cell & Gene Therapy Manufacturing
Whitepaper
13 June 2022
Cell Therapy Development

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login